Manuel Hidalgo
Tracked across 1 events · 74 articles · First seen Apr 15, 2026 · Last active Jun 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Manuel Hidalgo, director of NYU Grossman School of Medicine's Gastrointestinal Cancer Center, emphasized the drug's practice-changing potential and the need for further research into its efficacy across different genetic mutations.
May 29, 2026 · 74 articles
ERGEN INTELLIGENCE
Track Manuel Hidalgo live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard